Therapeutic Inhibitors against Mutated BRAF and MEK for the Treatment of Metastatic Melanoma

Melanoma is one of the most aggressive cancers in the world and is responsible for the majority of skin cancer deaths. Recent advances in the field of immunotherapy using active, adoptive, and antigen-specific therapeutic approaches, have generated the expectation that these technologies have the po...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Sunhyo, Youn, Chakyung, Moon, Ae Ran, Howland, Amanda, Armstrong, Cheryl A., Song, Peter I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chonnam National University Medical School 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636755/
https://www.ncbi.nlm.nih.gov/pubmed/29026704
http://dx.doi.org/10.4068/cmj.2017.53.3.173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636755/
https://www.ncbi.nlm.nih.gov/pubmed/29026704
http://dx.doi.org/10.4068/cmj.2017.53.3.173

Ejemplares similares